Vanda Pharmaceuticals Inc. SEC filings VNDA
Vanda Pharmaceuticals Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 10, 2009. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| S-3 | Shelf registration | Feb 12, 2026 | — |
| S-8 | Employee stock plan registration | Jun 5, 2025 | — |
| S-8 | Employee stock plan registration | May 21, 2024 | — |
| S-8 | Employee stock plan registration | Jun 8, 2023 | — |
| S-3/A | Filing | May 3, 2023 | — |
| S-3 | Shelf registration | Feb 9, 2023 | — |
| S-8 | Employee stock plan registration | Jun 17, 2022 | — |
| S-8 | Employee stock plan registration | Jun 10, 2021 | — |
| S-8 | Employee stock plan registration | Jun 11, 2020 | — |
| S-8 | Employee stock plan registration | Jun 13, 2018 | — |
| 424B5 | Prospectus supplement | Mar 16, 2018 | — |
| 424B5 | Prospectus supplement | Mar 14, 2018 | — |
| S-8 | Employee stock plan registration | Jun 15, 2017 | — |
| S-8 | Employee stock plan registration | Jun 27, 2016 | — |
| S-8 | Employee stock plan registration | Jan 28, 2016 | — |
| S-3 | Shelf registration | Jul 6, 2015 | — |
| S-8 | Employee stock plan registration | Jan 29, 2015 | — |
| 424B5 | Prospectus supplement | Dec 22, 2014 | — |
| 424B5 | Prospectus supplement | Oct 29, 2014 | — |
| 424B5 | Prospectus supplement | Oct 28, 2014 | — |
| S-8 | Employee stock plan registration | Jan 28, 2014 | — |
| S-3 | Shelf registration | Sep 27, 2013 | — |
| 424B5 | Prospectus supplement | Aug 7, 2013 | — |
| 424B5 | Prospectus supplement | Aug 6, 2013 | — |
| S-3MEF | Filing | Aug 6, 2013 | — |
| S-8 | Employee stock plan registration | Feb 8, 2013 | — |
| S-8 | Employee stock plan registration | Jan 31, 2012 | — |
| S-3 | Shelf registration | Jan 31, 2011 | — |
| S-8 | Employee stock plan registration | Jan 31, 2011 | — |
| S-8 | Employee stock plan registration | Jan 28, 2010 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VNDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Washington, DC
- SEC filer status
- Accelerated filer
- SEC CIK
- 1347178
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.